LORUSSO, BRUNO
 Distribuzione geografica
Continente #
NA - Nord America 2.188
AS - Asia 1.948
EU - Europa 1.645
SA - Sud America 283
AF - Africa 124
OC - Oceania 6
Totale 6.194
Nazione #
US - Stati Uniti d'America 2.113
IT - Italia 640
SG - Singapore 611
CN - Cina 468
VN - Vietnam 405
BR - Brasile 207
IE - Irlanda 190
HK - Hong Kong 158
DE - Germania 151
SE - Svezia 132
FR - Francia 93
ZA - Sudafrica 74
NL - Olanda 67
GB - Regno Unito 66
AT - Austria 62
IN - India 60
FI - Finlandia 58
RU - Federazione Russa 49
BD - Bangladesh 46
CA - Canada 41
TR - Turchia 29
AR - Argentina 27
JP - Giappone 24
IQ - Iraq 23
PL - Polonia 23
MX - Messico 22
BE - Belgio 21
CZ - Repubblica Ceca 21
PH - Filippine 19
CI - Costa d'Avorio 18
KR - Corea 17
EC - Ecuador 16
PK - Pakistan 15
UA - Ucraina 15
ES - Italia 14
CO - Colombia 10
IR - Iran 10
TH - Thailandia 10
ID - Indonesia 8
LT - Lituania 8
MA - Marocco 8
TN - Tunisia 8
VE - Venezuela 8
SA - Arabia Saudita 7
AU - Australia 6
EG - Egitto 6
RO - Romania 6
AZ - Azerbaigian 5
GR - Grecia 5
LU - Lussemburgo 5
PY - Paraguay 5
UY - Uruguay 5
UZ - Uzbekistan 5
IL - Israele 4
JO - Giordania 4
BG - Bulgaria 3
JM - Giamaica 3
KE - Kenya 3
MY - Malesia 3
PE - Perù 3
TW - Taiwan 3
BB - Barbados 2
CH - Svizzera 2
HN - Honduras 2
HR - Croazia 2
KH - Cambogia 2
KZ - Kazakistan 2
MD - Moldavia 2
NP - Nepal 2
OM - Oman 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
GP - Guadalupe 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 6.194
Città #
Ashburn 386
Singapore 367
Dallas 318
Dublin 190
Parma 188
San Jose 182
Chandler 159
Hong Kong 144
Ho Chi Minh City 123
Santa Clara 102
Boardman 98
Hanoi 89
Munich 77
Beijing 76
Johannesburg 68
New York 62
Los Angeles 59
Ann Arbor 55
Vienna 54
Bologna 53
Milan 48
Shanghai 47
Lauterbourg 44
Hefei 35
Dearborn 30
Helsinki 25
Frankfurt am Main 22
Moscow 22
Nanjing 22
Amsterdam 21
Buffalo 21
Bremen 20
São Paulo 20
Turku 20
Brussels 19
Chicago 19
Reggio Emilia 19
Verona 19
Abidjan 18
Haiphong 18
Tokyo 17
Princeton 16
Warsaw 16
Atlanta 15
Izmir 15
London 14
Modena 14
Montreal 14
Toronto 14
Rome 13
Baghdad 12
Da Nang 12
Nanchang 12
Brooklyn 11
Nuremberg 11
Rio Saliceto 11
Seoul 11
Columbus 10
Lahore 10
West Jordan 10
Brno 9
Carpi 9
Chongqing 9
Denver 9
Olomouc 9
Redondo Beach 9
The Dalles 9
Trento 9
Brescia 8
Fremont 8
Guangzhou 8
Hebei 8
Marseille 8
Pune 8
Rio de Janeiro 8
Seattle 8
Wilmington 8
Houston 7
Orem 7
Poplar 7
Curitiba 6
Jinan 6
Kyiv 6
Mexico City 6
Mumbai 6
Stockholm 6
Zhengzhou 6
Baku 5
Belo Horizonte 5
Bengaluru 5
Biên Hòa 5
Bolzano 5
Changsha 5
Charlotte 5
Chennai 5
Council Bluffs 5
Des Moines 5
Fidenza 5
Florence 5
Goiânia 5
Totale 3.889
Nome #
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors 217
1328P Dynamic blood immune-inflammatory and radiomic profiling to decode distinct patterns of acquired resistance to immunotherapy in NSCLC patients 214
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 209
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 208
227P Sexual dimorphism in immune profile of early and advanced NSCLC 200
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 179
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 177
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 176
189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC 175
LONGITUDINAL MONITORING OF RADIOMIC AND BLOOD IMMUNE-INFLAMMATORY DESCRIPTORS AS A NON-INVASIVE APPROACH TO PREDICT ICI EFFICACY IN ADVANCED NSCLC PATIENTS 174
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 173
In Vitro Biological and Functional Properties of Human Endothelial Cells from Different Sources Exposed to Different Beta-Blockers 167
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 165
Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 164
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 161
Assessment of Cardiac Patches Suitability for Tissue Engineering 158
2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients 156
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 154
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma 152
Isolation and characterization of human lung lymphatic endothelial cells 151
Identification of the Atypical Protein Kinase WNK1 As a New Target in T-Cell Acute Lymphoblastic Leukemia 147
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 145
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 144
Genetics of Darier’s Disease: New Insights into Pathogenic Mechanisms 141
Differential Pattern of Myocardial Remodelling in Genetically Determined and Load- Dependent Hypertrophy in Humans 141
Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens 140
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders 136
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 135
5P Blood immune-inflammatory dynamic unveils distinctive irAE features in ICI treated NSCLC 133
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 130
1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC 130
The Atypical Protein Kinase WNK1 Controls Leukemia Progression in TAL/LMO T-Cell Acute Lymphoblastic Leukemia 125
P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 124
IMPACT OF THE TISSUE DISTRIBUTION OF SUBPOPULATIONS OF TILS AND PD-L1 EXPRESSION ON THE CLINICAL OUTCOME OF NSCLC 124
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro 123
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 122
Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC 108
Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC 104
Deciphering the different patterns of acquired resistance in immunotherapy treated NSCLC patients through an integrated clinical and blood immuneinflammatory profiling 100
Longitudinal blood immune-inflammatory and radiomic profiling to decode different patterns acquired resistance to immunotherapy in patients with NSCLC 97
CD26 is differentially expressed throughout the life cycle of infantile hemangiomas and characterizes the proliferative phase 91
Deciphering multifaceted connections between NOTCH1 and SERCA2 proteins in the Darier's disease: a paradigmatic molecular network in the pathogenesis of a Mendelian genodermatosis 58
EHMT2/G9A drives the epigenetic regulation of glucose metabolism in T-cell Acute lymphoblastic leukemia 48
Totale 6.276
Categoria #
all - tutte 19.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.808


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 0 0 0 7 29 6
2021/202291 8 5 2 6 1 4 15 7 2 5 4 32
2022/2023767 58 70 40 71 110 72 26 45 214 7 39 15
2023/2024510 24 22 21 26 50 72 83 20 31 48 29 84
2024/20251.247 63 64 92 112 113 82 105 74 116 102 109 215
2025/20263.226 288 227 547 361 385 211 298 160 509 240 0 0
Totale 6.276